Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS)

Status:
Completed

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Study is to assess the effectiveness of TC-6499 in the treatment of constipation predominant IBS patients over a 28-day period.

Phase 2

Targacept Inc.